Identification of differentially expressed genes in pancreatic cancer cells using cDNA microarray

Cancer Research

Volumn 62, Issue 10, 2002, Pages 2890-2896

  Han, Haiyong ^a   Bearss, David J ^a   Browne, L Walden ^b   Calaluce, Robert ^a,b   Nagle, Raymond B ^a,b   Von Hoff, Daniel D ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OXIDOREDUCTASE; PROTEIN SERINE KINASE; PROTEIN SERINE THREONINE KINASE; RAD51 PROTEIN; THIOREDOXIN; UROKINASE RECEPTOR;

ARTICLE; CANCER CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; GENE EXPRESSION; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENE PROBE; GENE SEQUENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; NORTHERN BLOTTING; ONCOGENE C MYC; PANCREAS CANCER; PRIORITY JOURNAL; RECEPTOR UPREGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; TISSUE CULTURE; UNINDEXED SEQUENCE;

BLOTTING, NORTHERN; DNA, COMPLEMENTARY; DNA-BINDING PROTEINS; GENE EXPRESSION PROFILING; HELA CELLS; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PANCREATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-MYC; RAD51 RECOMBINASE; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0037093087     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. STI571: A gene product-targeted therapy for leukemia
2. Progress in cancer genetics: Lessons from pancreatic cancer
3. Molecular technology and pancreatic cancer
4. Molecular genetic alterations in ductal pancreatic adenocarcinomas
5. Molecular biology of pancreatic cancer; oncogenes, tumour suppressor genes, growth factors, and their receptors from a clinical perspective
6. Tumor-suppressor genes in pancreatic cancer
7. Ki-ras point mutation and p53 expression in human pancreatic cancer: A comparative study among Chinese, Japanese, and Western patients
8. Frequent loss of p16 expression and its correlation with clinicopathological parameters in pancreatic carcinoma
9. Dpc-4 protein is expressed in virtually all human intraductal papillary mucinous neoplasms of the pancreas: Comparison with conventional ductal adenocarcinomas
10. Familial pancreatic cancer
11. Genetic alterations of the transforming growth factor β receptor genes in pancreatic and biliary adenocarcinomas
12. Alterations in pancreatic, biliary, and breast carcinomas support MKK4 as a genetically targeted tumor suppressor gene
13. Germline and somatic mutations of the STK11/LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers
14. Patterns of genetic alterations in pancreatic cancer: A pooled analysis
15. Immunohistochemical evaluation of HER-2/neu expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasms
16. Cyclooxygenase-2 expression in human pancreatic adenocarcinomas
17. De novo expression of vascular endothelial growth factor in human pancreatic cancer: Evidence for an autocrine mitogenic loop
18. DNA mismatch repair and cancer
19. Genetic and clinical features of human pancreatic ductal adenocarcinomas with widespread microsatellite instability
20. High throughput analysis of differential gene expression
21. The application of DNA microarrays in gene expression analysis
22. Proteomics to study genes and genomes
23. Enhanced expression of epidermal growth factor receptor correlates with alterations of chromosome 7 in human pancreatic cancer
24. Laminin-5-mediated gene expression in human prostate carcinoma cells
25. Tissue microarrays for high-throughput molecular profiling of tumor specimens
26. Differentially expressed genes in two LNCaP prostate cancer cell lines reflecting changes during prostate cancer progression
27. An approach to proteomic analysis of human tumors
28. MYC oncogenes and human neoplastic disease
29. The plasminogen activation system in tumor growth, invasion, and metastasis
30. Architectural transcription factor HMGI(Y) promotes tumor progression and mesenchymal transition of human epithelial cells
31. Expression of the HMGI(Y) gene products in human neuroblastic tumours correlates with differentiation status
32. Cell proliferation indexes: A biomarker in solid tumors
33. Nonspecific cross-reacting antigen-50/90 (NCA-50/90) as a new tumor marker
34. Mitochondria: Execution central
35. Rad51/RecA protein families and the associated proteins in eukaryotes
36. Downregulation of gelsolin correlates with the progression to breast carcinoma
37. Landi differential susceptibility to carcinogens: A review
38. Death-associated proteins: From gene identification to the analysis of their apoptotic and tumour suppressive functions
39. Death-associated protein kinase-related protein 1, a novel serine/threonine kinase involved in apoptosis
40. The DAP kinase family of proapoptotic proteins: Novel players in the apoptotic game
41. Role of urokinase (uPA) and its receptor (uPAR) in invasion and metastasis of hormone-dependent malignancies
42. The mitogen-inducible Fn14 gene encodes a type I transmembrane protein that modulates fibroblast adhesion and migration
43. Protein abundance alterations in matched sets of macroscopically normal colon mucosa and colorectal carcinoma
44. The identification and differential expression of calcium-binding proteins associated with ocular melanoma
45. Differential expression of annexin 1 in human mammary ductal epithelial cells in normal and benign and malignant breast tissues
46. Tumour amplified kinase STKI5/BTAK induces centrosome amplification, aneuploidy and transformation
47. ckshs expression is linked to cell proliferation in normal and malignant human lymphoid cells
48. DNA repair and recombination factor Rad51 is over-expressed in human pancreatic adenocarcinoma
49. Over-expression of wild-type Rad51 correlates with histological grading of invasive ductal breast cancer